NCT00249860: A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects |
|
|
| Completed | 3 | 257 | RoW | Interferon-beta-1a, Placebo, Ribavirin plus Interferon-beta-1a | EMD Serono, Merck Pte. Ltd., Singapore | Hepatitis C | 08/05 | 08/05 | | |
